Brief: Roche Receives CE Mark For New Blood Test To Detect Alzheimer's Pathology
12/05/2026 06:00
May 12 (Reuters) - ROCHE HOLDING AG ROPC.S: RECEIVES CE MARK FOR NEW BLOOD TEST TO DETECT ALZHEIMER'S PATHOLOGY Further company coverage: ROPC.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))
Recent news on Roche Holding AG
See all newsTable: Swiss trade surplus at CHF 6.11 bln in May
Brief: Roche - FDA Accepts Supplemental Biologics License Application For Lunsumio And Polivy Combination
Swiss stocks - Factors to watch on June 18
FDA approves first generic version of Roche's flu drug
Brief: FDA Approves First Single-Dose Generic Treatment For Influenza